Plasma Parathyroid Hormone Levels and Bone Associated Biomarkers in Postmenopausal Women: Insights into Osteoporosis Risk Assessment

ATERE, Adedeji; EHUINE, Elizabeth; KOSAMAT, Yekeen; IGE, Ilesanmi

Back to the articles list | Back to browse issues page

Plasma Parathyroid Hormone Levels and Bone Associated Biomarkers in Postmenopausal Women: Insights into Osteoporosis Risk Assessment

Adedeji ATERE¹

, Elizabeth EHUINE²

, Yekeen KOSAMAT³

, Ilesanmi IGE²

1- Faculty of Basic Medical Sciences, Osun State University, Osogbo, Osun State, Nigeria , adedeji.atere@uniosun.edu.ng
2- Achievers University, Owo, Ondo State, Nigeria
3- Faculty of Basic Medical Sciences, Osun State University, Osogbo, Osun State, Nigeria

Abstract: (120 Views)

Background: Menopause, characterized by the cessation of menstrual periods, often leads to bone diseases due to hormonal changes, particularly affecting calcium metabolism. This study aimed to evaluate bone-associated biomarkers and their correlation with parathyroid hormone (PTH) levels in postmenopausal women, shedding light on potential osteoporosis risks.
Methods: Sixty postmenopausal (PMP) women, along with 20 premenopausal (PRM) and 20 reproductive-age (RWA) women as controls, were included in this cross-sectional study. Blood samples were analyzed for PTH, vitamin D, uric acid, calcium, phosphorus, alkaline phosphatase (ALP), and estradiol levels.
Results: Statistical analysis revealed significantly higher levels of ALP and phosphorus, and lower levels of calcium, PTH, vitamin D, uric acid and estradiol in PMP and PRM groups compared to RWA (p<0.05). Moreover, PTH exhibited a significant negative correlation with ALP, and phosphorus, but a positive correlation with calcium, vitamin D, and estradiol in PMP women. ALP demonstrated a superior area under the ROC curve (AUROC) compared to other bone markers.
Conclusion: These findings highlight the reduced bone marker levels in postmenopausal women, potentially increasing the risk of bone loss and osteoporosis.

Keywords: osteoporosis, postmenopause, hyperparathyroidism, bone density, vitamin D

Full-Text [PDF 375 kb] (19 Downloads)

Research Article: Research Article | Subject: Laboratory Sciences
Received: 2024/06/24 | Accepted: 2024/11/3

References

1. Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015;99(3):521-34. [View at Publisher] [DOI] [PMID]

2. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012;94(4):843-51. [View at Publisher] [DOI] [PMID] [Google Scholar]

3. Scally NP, Armstrong L, Blades D, McGeown E, Mathers H. Menopausal Symptoms and Utian Quality of Life Scale Following a Breast Cancer Diagnosis and Its Impact on Endocrine Adherence. Cureus. 2024;16(1):e52777. [View at Publisher] [DOI] [PMID] [Google Scholar]

4. Effendy NM, Shuid AN. Time and dose-dependent effects of Labisia pumila on bone oxidative status of postmenopausal osteoporosis rat model. Nutrients. 2014;6(8):3288-302. [View at Publisher] [DOI] [PMID] [Google Scholar]

5. Park JM, Lee YJ. Serum oestradiol levels are inversely associated with C-reactive protein levels in premenopausal women, but not postmenopausal women. J Int Med Res. 2020;48(10):300060520961228. [View at Publisher] [DOI] [PMID] [Google Scholar]

6. Anklam CFV, Lissarassa YPS, Dos Santos AB, Costa-Beber LC, Sulzbacher LM, Goettems-Fiorin PB, et al. Oxidative and Cellular Stress Markers in Postmenopause Women with Diabetes: The Impact of Years of Menopause. J Diabetes Res. 2021;2021:3314871. [View at Publisher] [DOI] [PMID] [Google Scholar]

7. Tuchendler D, Bolanowski M. Assessment of bone metabolism in premenopausal females with hyperthyroidism and hypothyroidism. Endokrynol Pol. 2013;64(1):40-4. [View at Publisher] [PMID] [Google Scholar]

8. Kužma M, Jackuliak P, Killinger Z, Payer J. Parathyroid Hormone-Related Changes of Bone Structure. Physiol Res. 2021;70:3-11. [View at Publisher] [DOI] [PMID] [Google Scholar]

9. Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: A reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr. 2011;94(4):1144-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

10. Holick MF. Vitamin D: a d-lightful solution for health. J Investig Med. 2011;59(6):872-80. [View at Publisher] [DOI] [PMID] [Google Scholar]

11. Khan AW, Zadran N, Khan A, Ishaq M, Kumar J, Ibrar A, et al. Vitamin D Levels and Bone Mineral Density in Premenopausal Women Compared to Postmenopausal Women: A Multi-Centre Study from Pakistan. Cureus. 2020;12(11):e11439. [View at Publisher] [DOI] [PMID] [Google Scholar]

12. Rosen CJ, Bilezikian JP. Clinical review 123: Hot topic - Anabolic therapy for osteoporosis. J Clin Endocrinol Metab. 2001;86(3):957-64. [View at Publisher] [DOI] [PMID] [Google Scholar]

13. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s-9s. [View at Publisher] [DOI] [PMID] [Google Scholar]

14. Milic J, Renzetti S, Morini D, Motta F, Carli F, Menozzi M, et al. Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV. Viruses. 2023;15(12):2375. [View at Publisher] [DOI] [PMID] [Google Scholar]

15. Daniel WW, Crross CL. BIOSTATISTICS. A Foundation For Analysis In The Health Sciences. 2013. [View at Publisher] [Google Scholar]

16. Adewole OA, Idowu SO, Shoga MO, Kayode MO, Adelowo OO. Frequency of Osteoporosis in Black Nigerian Women Aged 50 and above with Degenerative Musculoskeletal Diseases and Fractures. West Afr J Med. 2021;38(4):342-6. [View at Publisher] [PMID] [Google Scholar]

17. Atere AD, Moronkeji A, Moronkeji AI, Osadolor HB. Serum levels of inflammatory biomarkers, glycaemic control indices and leptin receptors expression in adult male Wistar rats exposed to Pyrethroids. J Cell Biotechnol. 2021;7(1):41-55. [View at Publisher] [DOI] [Google Scholar]

18. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R, et al. Menopause-related blood pressure increase and its relationship to age and body mass index: The SIMONA epidemiological study. J Hypertens. 2005;23(12):2269-76. [View at Publisher] [DOI] [PMID] [Google Scholar]

19. Achie LN, Olorunshola K V, Igashi J, Toryila JE. Assessment of the levels of serum parathyroid hormone in rural postmenopausal women in Zuturung district, Zangon Kataf Local Government Area, Kaduna State, Nigeria. J Afr Assoc Physiol Sci. 2021;9(2):130-7. [View at Publisher] [Google Scholar]

20. Tuomisto H, Salo P, Saarinen R, Kalleinen N, Polo-Kantola P. The association of serum oestradiol level, age, and education with cognitive performance in peri- and late postmenopausal women. Maturitas. 2012;71(2):173-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

21. Cano A, Chedraui P, Goulis DG, Lopes P, Mishra G, Mueck A, et al. Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide. Maturitas. 2018;107:7-12. [View at Publisher] [DOI] [PMID] [Google Scholar]

22. Pardhe BD, Pathak S, Bhetwal A, Ghimire S, Shakya S, Khanal PR, et al. Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal. Int J Womens Health. 2017;9:781-8. [View at Publisher] [DOI] [PMID] [Google Scholar]

23. Oluboyo AO, Anaenye C V, Oluboyo BO, Ajayi FO. Assessment of the Levels of Parathyroid Hormone, Oestrogen and Selected Bone Minerals in Menopausal Women. Am J Biomed Sci. 2018;10(4):189-194. [View at Publisher] [DOI] [Google Scholar]

24. Shi JW, Wu JN, Zhu XY, Zhou WH, Yang JY, Li MQ. Association of serum 25-hydroxyvitamin D levels with all-cause and cause-specific mortality among postmenopausal females: results from NHANES. J Transl Med. 2023;21(1):1-11. [View at Publisher] [DOI] [PMID] [Google Scholar]

25. Raju A, Luthra G, Shahbaz M, Almatooq H, Foucambert P, Esbrand FD, et al. Role of Vitamin D Deficiency in Increased Susceptibility to Respiratory Infections Among Children: A Systematic Review. Cureus. 2022;14(9):e29205. [View at Publisher] [DOI] [PMID] [Google Scholar]

26. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women - The Third National Health and Nutrition Examination Survey. Arthritis Res Ther. 2008;10(5):1-7. [View at Publisher] [DOI] [PMID] [Google Scholar]

27. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):608-19. [View at Publisher] [DOI] [PMID] [Google Scholar]